Platelet derived growth factor and subarachnoid haemorrage: A study on cisternal cerebrospinal fluid

P. Gaetani, F. Tancioni, G. Grignani, F. Tartara, E. M. Merlo, A. Brocchieri, R. Rodriguez Y Baena

Research output: Contribution to journalArticle

Abstract

Platelet derived growth factor (PDGF) was identified as a powerful mitogenic growth factor which is released from activated platelets and has a marked activity as vasoconstrictor agent. In the present study we have measured cisternal cerebrospinal fluid (CSF) levels of PDGF in 72 patients operated on for intracranial aneurysm in order to verify whether it might be related to the clinical aspects of SAH with special regard to symptomatic vasospasm. CSF samples were obtained at surgery by cisternal puncture of the subarachnoid cistern the nearest to the aneurysm before aneurysm isolation and exclusion. The specimen were frozen in liquid nitrogen and stored at -80°C until analysis. PDGF was measured using a commercially available reagent. Values are expressed as pg/ml of CSF. In 18 cases no radiological and clinical signs of SAH were detected and the mean cisternal CSF level of PDGF was 885.0 ± 104.5 pg/ml; 20 patients were operated on between day 1 and 3 from the last SAH episode: mean cisternal CSF level of PDGF was 1917.5 ± 459.4 pg/ml. In 34 patients treated with delayed surgery protocol, mean cisternal CSF level of PDGF was 995.3 ± 73.8 pg/ml. Statistical analysis showed significant differences between groups (P: 0.011). In the subgroup of patients operated on within day 3 after SAH, 6 presented vasospasm and had mean cisternal CSF PDGF level which was significantly higher (P <0.01) than in 14 patients without vasospasm. In the delayed 'surgical' patients there was no significant difference in cisternal CSF levels of PDGF considering the occurrence of vasospasm. The results of the present study suggest that (a) after SAH there is a significant release of PDGF early after SAH and (b) higher levels of PDGF found in cisternal CSF of patients operated on within 72 hours after SAH may be predictive of symptomatic vasospasm.

Original languageEnglish
Pages (from-to)319-324
Number of pages6
JournalActa Neurochirurgica
Volume139
Issue number4
Publication statusPublished - 1997

Fingerprint

Platelet-Derived Growth Factor
Cerebrospinal Fluid
Aneurysm
Intracranial Aneurysm
Vasoconstrictor Agents
Punctures
Intercellular Signaling Peptides and Proteins
Nitrogen
Blood Platelets

Keywords

  • Intracranial aneurysm
  • Platelet derived growth factor
  • Subarachnoid haemorrhage
  • Vasospasm

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

Gaetani, P., Tancioni, F., Grignani, G., Tartara, F., Merlo, E. M., Brocchieri, A., & Rodriguez Y Baena, R. (1997). Platelet derived growth factor and subarachnoid haemorrage: A study on cisternal cerebrospinal fluid. Acta Neurochirurgica, 139(4), 319-324.

Platelet derived growth factor and subarachnoid haemorrage : A study on cisternal cerebrospinal fluid. / Gaetani, P.; Tancioni, F.; Grignani, G.; Tartara, F.; Merlo, E. M.; Brocchieri, A.; Rodriguez Y Baena, R.

In: Acta Neurochirurgica, Vol. 139, No. 4, 1997, p. 319-324.

Research output: Contribution to journalArticle

Gaetani, P, Tancioni, F, Grignani, G, Tartara, F, Merlo, EM, Brocchieri, A & Rodriguez Y Baena, R 1997, 'Platelet derived growth factor and subarachnoid haemorrage: A study on cisternal cerebrospinal fluid', Acta Neurochirurgica, vol. 139, no. 4, pp. 319-324.
Gaetani P, Tancioni F, Grignani G, Tartara F, Merlo EM, Brocchieri A et al. Platelet derived growth factor and subarachnoid haemorrage: A study on cisternal cerebrospinal fluid. Acta Neurochirurgica. 1997;139(4):319-324.
Gaetani, P. ; Tancioni, F. ; Grignani, G. ; Tartara, F. ; Merlo, E. M. ; Brocchieri, A. ; Rodriguez Y Baena, R. / Platelet derived growth factor and subarachnoid haemorrage : A study on cisternal cerebrospinal fluid. In: Acta Neurochirurgica. 1997 ; Vol. 139, No. 4. pp. 319-324.
@article{4877ff0c4ff1442a9cc72a1a4bf040fc,
title = "Platelet derived growth factor and subarachnoid haemorrage: A study on cisternal cerebrospinal fluid",
abstract = "Platelet derived growth factor (PDGF) was identified as a powerful mitogenic growth factor which is released from activated platelets and has a marked activity as vasoconstrictor agent. In the present study we have measured cisternal cerebrospinal fluid (CSF) levels of PDGF in 72 patients operated on for intracranial aneurysm in order to verify whether it might be related to the clinical aspects of SAH with special regard to symptomatic vasospasm. CSF samples were obtained at surgery by cisternal puncture of the subarachnoid cistern the nearest to the aneurysm before aneurysm isolation and exclusion. The specimen were frozen in liquid nitrogen and stored at -80°C until analysis. PDGF was measured using a commercially available reagent. Values are expressed as pg/ml of CSF. In 18 cases no radiological and clinical signs of SAH were detected and the mean cisternal CSF level of PDGF was 885.0 ± 104.5 pg/ml; 20 patients were operated on between day 1 and 3 from the last SAH episode: mean cisternal CSF level of PDGF was 1917.5 ± 459.4 pg/ml. In 34 patients treated with delayed surgery protocol, mean cisternal CSF level of PDGF was 995.3 ± 73.8 pg/ml. Statistical analysis showed significant differences between groups (P: 0.011). In the subgroup of patients operated on within day 3 after SAH, 6 presented vasospasm and had mean cisternal CSF PDGF level which was significantly higher (P <0.01) than in 14 patients without vasospasm. In the delayed 'surgical' patients there was no significant difference in cisternal CSF levels of PDGF considering the occurrence of vasospasm. The results of the present study suggest that (a) after SAH there is a significant release of PDGF early after SAH and (b) higher levels of PDGF found in cisternal CSF of patients operated on within 72 hours after SAH may be predictive of symptomatic vasospasm.",
keywords = "Intracranial aneurysm, Platelet derived growth factor, Subarachnoid haemorrhage, Vasospasm",
author = "P. Gaetani and F. Tancioni and G. Grignani and F. Tartara and Merlo, {E. M.} and A. Brocchieri and {Rodriguez Y Baena}, R.",
year = "1997",
language = "English",
volume = "139",
pages = "319--324",
journal = "Acta Neurochirurgica",
issn = "0001-6268",
publisher = "Springer Wien",
number = "4",

}

TY - JOUR

T1 - Platelet derived growth factor and subarachnoid haemorrage

T2 - A study on cisternal cerebrospinal fluid

AU - Gaetani, P.

AU - Tancioni, F.

AU - Grignani, G.

AU - Tartara, F.

AU - Merlo, E. M.

AU - Brocchieri, A.

AU - Rodriguez Y Baena, R.

PY - 1997

Y1 - 1997

N2 - Platelet derived growth factor (PDGF) was identified as a powerful mitogenic growth factor which is released from activated platelets and has a marked activity as vasoconstrictor agent. In the present study we have measured cisternal cerebrospinal fluid (CSF) levels of PDGF in 72 patients operated on for intracranial aneurysm in order to verify whether it might be related to the clinical aspects of SAH with special regard to symptomatic vasospasm. CSF samples were obtained at surgery by cisternal puncture of the subarachnoid cistern the nearest to the aneurysm before aneurysm isolation and exclusion. The specimen were frozen in liquid nitrogen and stored at -80°C until analysis. PDGF was measured using a commercially available reagent. Values are expressed as pg/ml of CSF. In 18 cases no radiological and clinical signs of SAH were detected and the mean cisternal CSF level of PDGF was 885.0 ± 104.5 pg/ml; 20 patients were operated on between day 1 and 3 from the last SAH episode: mean cisternal CSF level of PDGF was 1917.5 ± 459.4 pg/ml. In 34 patients treated with delayed surgery protocol, mean cisternal CSF level of PDGF was 995.3 ± 73.8 pg/ml. Statistical analysis showed significant differences between groups (P: 0.011). In the subgroup of patients operated on within day 3 after SAH, 6 presented vasospasm and had mean cisternal CSF PDGF level which was significantly higher (P <0.01) than in 14 patients without vasospasm. In the delayed 'surgical' patients there was no significant difference in cisternal CSF levels of PDGF considering the occurrence of vasospasm. The results of the present study suggest that (a) after SAH there is a significant release of PDGF early after SAH and (b) higher levels of PDGF found in cisternal CSF of patients operated on within 72 hours after SAH may be predictive of symptomatic vasospasm.

AB - Platelet derived growth factor (PDGF) was identified as a powerful mitogenic growth factor which is released from activated platelets and has a marked activity as vasoconstrictor agent. In the present study we have measured cisternal cerebrospinal fluid (CSF) levels of PDGF in 72 patients operated on for intracranial aneurysm in order to verify whether it might be related to the clinical aspects of SAH with special regard to symptomatic vasospasm. CSF samples were obtained at surgery by cisternal puncture of the subarachnoid cistern the nearest to the aneurysm before aneurysm isolation and exclusion. The specimen were frozen in liquid nitrogen and stored at -80°C until analysis. PDGF was measured using a commercially available reagent. Values are expressed as pg/ml of CSF. In 18 cases no radiological and clinical signs of SAH were detected and the mean cisternal CSF level of PDGF was 885.0 ± 104.5 pg/ml; 20 patients were operated on between day 1 and 3 from the last SAH episode: mean cisternal CSF level of PDGF was 1917.5 ± 459.4 pg/ml. In 34 patients treated with delayed surgery protocol, mean cisternal CSF level of PDGF was 995.3 ± 73.8 pg/ml. Statistical analysis showed significant differences between groups (P: 0.011). In the subgroup of patients operated on within day 3 after SAH, 6 presented vasospasm and had mean cisternal CSF PDGF level which was significantly higher (P <0.01) than in 14 patients without vasospasm. In the delayed 'surgical' patients there was no significant difference in cisternal CSF levels of PDGF considering the occurrence of vasospasm. The results of the present study suggest that (a) after SAH there is a significant release of PDGF early after SAH and (b) higher levels of PDGF found in cisternal CSF of patients operated on within 72 hours after SAH may be predictive of symptomatic vasospasm.

KW - Intracranial aneurysm

KW - Platelet derived growth factor

KW - Subarachnoid haemorrhage

KW - Vasospasm

UR - http://www.scopus.com/inward/record.url?scp=0030999034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030999034&partnerID=8YFLogxK

M3 - Article

C2 - 9202771

AN - SCOPUS:0030999034

VL - 139

SP - 319

EP - 324

JO - Acta Neurochirurgica

JF - Acta Neurochirurgica

SN - 0001-6268

IS - 4

ER -